Literature DB >> 17259475

Effects of treatment targets on subsequent cardiovascular events in Chinese patients with type 2 diabetes.

Alice P S Kong1, Xilin Yang, Gary T C Ko, Wing-Yee So, Wing-Bun Chan, Ronald C W Ma, Vanessa W S Ng, Chun-Chung Chow, Clive S Cockram, Peter C Y Tong, Vivian Wong, Juliana C N Chan.   

Abstract

OBJECTIVE: International guidelines recommend optimal control of risk factors in diabetes to prevent cardiovascular events. We examined risk associations between achieving treatment targets for glycemia, blood pressure and lipid control, and other risk factors on subsequent cardiovascular events in Chinese patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: Between 1995 and 2005, 6,386 Chinese type 2 diabetic patients without a history of coronary heart disease (CHD) or stroke were recruited. They were classified according to the number of treatment targets attained at baseline, and their cardiovascular outcomes were compared. Treatment targets were defined as A1C <7.0%, blood pressure <130/80 mmHg, and LDL cholesterol <2.6 mmol/l.
RESULTS: After a median follow-up of 5.7 years, cumulative incidence of CHD or stroke (n = 749) increased with decreasing numbers of treatment targets attained at baseline. Attainment of two or more targets at baseline was associated with reduced risk of CHD compared with those with no target achieved (hazard ratio 0.69 [95% CI 0.50-0.94], P = 0.020). However, the association lost its significance after adjustment for urinary albumin-to-creatinine ratio, estimated glomerular filtration rate, and hemoglobin.
CONCLUSIONS: Reaching more treatment targets was associated with reduced risk of new onset of CHD in Chinese patients with type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17259475     DOI: 10.2337/dc06-2443

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  16 in total

1.  Long-term outcomes associated with triple-goal achievement in patients with type 2 diabetes mellitus (T2DM).

Authors:  Qian Shi; Shuqian Liu; Marie Krousel-Wood; Hui Shao; Vivian Fonseca; Lizheng Shi
Journal:  Diabetes Res Clin Pract       Date:  2018-03-27       Impact factor: 5.602

2.  Combined associations of family history and self-management with age at diagnosis and cardiometabolic risk in 86,931 patients with type 2 diabetes: Joint Asia Diabetes Evaluation (JADE) Register from 11 countries.

Authors:  Johnny T K Cheung; Eric Lau; Cyrus C T Tsui; Edmond L N Siu; Naomi K W Tse; Nicole Y L Hui; Ronald C W Ma; Alice P S Kong; Amy Fu; Vanessa Lau; Weiping Jia; Wayne H H Sheu; Leorino Sobrepena; K H Yoon; Alexander T B Tan; Yook-Chin Chia; Aravind Sosale; Banshi D Saboo; Jothydev Kesavadev; Su-Yen Goh; Thy Khue Nguyen; Yotsapon Thewjitcharoen; Raymond Suwita; Andrea O Y Luk; Aimin Yang; Elaine Chow; Lee Ling Lim; Juliana C N Chan
Journal:  BMC Med       Date:  2022-07-14       Impact factor: 11.150

3.  From design to implementation--the Joint Asia Diabetes Evaluation (JADE) program: a descriptive report of an electronic web-based diabetes management program.

Authors:  Gary T Ko; Wing-Yee So; Peter C Tong; Francois Le Coguiec; Debborah Kerr; Greg Lyubomirsky; Beaver Tamesis; Troels Wolthers; Jennifer Nan; Juliana Chan
Journal:  BMC Med Inform Decis Mak       Date:  2010-05-13       Impact factor: 2.796

4.  The Complexity of Vascular and Non-Vascular Complications of Diabetes: The Hong Kong Diabetes Registry.

Authors:  Juliana C N Chan; Wingyee So; Ronald C W Ma; Peter C Y Tong; Rebecca Wong; Xilin Yang
Journal:  Curr Cardiovasc Risk Rep       Date:  2011-04-12

5.  Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study.

Authors:  Rose Z W Ting; Xilin Yang; Linda W L Yu; Andrea O Y Luk; Alice P S Kong; Peter C Y Tong; Wing-Yee So; Juliana C N Chan; Ronald C W Ma
Journal:  Cardiovasc Diabetol       Date:  2010-11-22       Impact factor: 9.951

6.  Cardiovascular risk factor treatment targets and renal complications in high risk vascular patients: a cohort study.

Authors:  Sharmini Selvarajah; Yolanda van der Graaf; Frank L J Visseren; Michiel L Bots
Journal:  BMC Cardiovasc Disord       Date:  2011-07-05       Impact factor: 2.298

7.  Intensive diabetes management for high-risk patients: how best to deliver?

Authors:  Sally M Marshall
Journal:  Diabetes Care       Date:  2009-06       Impact factor: 19.112

8.  Effects of structured versus usual care on renal endpoint in type 2 diabetes: the SURE study: a randomized multicenter translational study.

Authors:  Juliana C Chan; Wing-Yee So; Chun-Yip Yeung; Gary T Ko; Ip-Tim Lau; Man-Wo Tsang; Kam-Piu Lau; Sing-Chung Siu; June K Li; Vincent T Yeung; Wilson Y Leung; Peter C Tong
Journal:  Diabetes Care       Date:  2009-06       Impact factor: 19.112

9.  Validation of methods to control for immortal time bias in a pharmacoepidemiologic analysis of renin-angiotensin system inhibitors in type 2 diabetes.

Authors:  Xilin Yang; Alice Ps Kong; Andrea Oy Luk; Risa Ozaki; Gary Tc Ko; Ronald Cw Ma; Juliana Cn Chan; Wing Yee So
Journal:  J Epidemiol       Date:  2014-04-19       Impact factor: 3.211

10.  Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes.

Authors:  Alice P S Kong; Xilin Yang; Wing-Yee So; Andrea Luk; Ronald C W Ma; Risa Ozaki; Kitty K T Cheung; Heung-Man Lee; Linda Yu; Gang Xu; Chun-Chung Chow; Juliana C N Chan
Journal:  BMC Med       Date:  2014-05-13       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.